Date	Period	Revenue/Estimate	Earnings Call
May 12, 2023	2023/Q1	35.000M / --	--
Nov 4, 2022	2022/Q3	358.000M / --	--
May 13, 2022	2022/Q1	193.000M / --	--
Nov 5, 2021	2021/Q3	125.000M / --	--
May 7, 2021	2021/Q1	62.000M / --	--
Dec 6, 2020	2020/Q3	71.000M / --	--
May 8, 2020	2020/Q1	70.000M / --	--
Nov 1, 2019	2019/Q3	19.000M / --	--
May 10, 2019	2019/Q1	48.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

May 12, 20232023/Q135.000M / ----

Nov 4, 20222022/Q3358.000M / ----

May 13, 20222022/Q1193.000M / ----

Nov 5, 20212021/Q3125.000M / ----

May 7, 20212021/Q162.000M / ----

Dec 6, 20202020/Q371.000M / ----

May 8, 20202020/Q170.000M / ----

Nov 1, 20192019/Q319.000M / ----

May 10, 20192019/Q148.000M / ----

--------

Unlock Free Earnings Estimates

Open Account

Oncolys BioPharma: Confirmation letter

May 10 14:08

Oncolys BioPharma: Quarterly Report - 21st Quarter (2024/01/01 to 2024/03/31)

May 10 14:07

Oncolys BioPharma: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

May 10 14:00

Oncolys BioPharma: Extraordinary Report

Apr 3 08:44

No Data

No Data

Overall

4588 Oncolys BioPharma

Oncolys BioPharma Key Stats